Skip to content
healthcare.dev
Get a free key

ENTYVIO Pen

NDC 64764-108, vedolizumab, injection, solution, from Takeda Pharmaceuticals America, Inc..

Product NDC
64764-108
Status
Listed
Labeler
Takeda Pharmaceuticals America, Inc.
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761133
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/64764-108 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • VEDOLIZUMAB108 mg/.68mL

Pharmacologic classes

Integrin Receptor Antagonist [EPC]; Integrin Receptor Antagonists [MoA]

Package NDCNDC-11Package
64764-108-21647640108211 TRAY in 1 CARTON (64764-108-21) / 1 SYRINGE in 1 TRAY (64764-108-20) / .68 mL in 1 SYRINGE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/6e94621c-1a95-4af9-98d1-52b9e6f1949c

Use it

Look up 64764-108 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/64764-108 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 64764-108. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.